Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
238 Leser
Artikel bewerten:
(1)

CBD Life Sciences Inc. Announces Its New Product "CBD Honey Sticks"

SCOTTSDALE, AZ / ACCESSWIRE / June 9, 2020 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. is pleased to announce that our new product "CBD Honey Sticks"arrived to our facility and is readily available to be purchased. The product consists of 10 Organic Brazilian Rainforest Honey sticks with 8-10 MGS of CBD per stick with zero THC. The product is meant to consumed by putting the honey into a drink, food or as is. Consumers can instantly feel the effects of CBD such as pain relief, anxiety relief, stress relief and more! The product is retailing for $15.99 and consumers can place their order today on our website at www.lbcbioscienceinc.com.

The CBD "(cannabidiol) market is rapidly growing and has shown promising indication for the health & wellness industry. Widespread use is increasing throughout the public. Follow our social media accounts at www.instagram.com/lbcbioscience, www.facebook.com/lbcbioscience, www.linkedin.com/company/lbcbioscienceinc & www.twitter.com/lbcbioscience for updating information.

Lisa Nelson, President/CEO of CBD Life Sciences, Inc. commented "I am delighted to announce that our new product (CBD Honey Sticks) are available for consumers to purchase. Our buyers can easily consume CBD through ingesting our CBD Honey Sticks. The product goes great in tea, oatmeal, yogurt, coffee & more! I'm anticipating on our customers trying out our latest product and letting us know their opinion."

Lisa Nelson continued "CBD Honey Sticks are a new Cannabidiol product on the market and has many benefits such as immune boosting, antibacterial health, digestive health, antioxidant and much more." Lisa ended with "As always, the Company will continue to update the public about new product releases, trades shows, events and any updated information regarding LBC Bioscience Inc."

About LBC Bioscience Inc.

LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including: CBD Drops, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets. LBC's products can be viewed and purchased on the Company's website at www.lbcbioscienceinc.com.

Ten Associates LLC

Contact: Thomas E. Nelson
Telephone: (480) 326-8577
Email: tenassociates33@gmail.com
Website: www.tenassociatesllc.com

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking.

SOURCE: CBD Life Sciences Inc.



View source version on accesswire.com:
https://www.accesswire.com/593184/CBD-Life-Sciences-Inc-Announces-Its-New-Product-CBD-Honey-Sticks

© 2020 ACCESS Newswire
Epische Goldpreisrallye
Der Goldpreis hat ein neues Rekordhoch überschritten. Die Marke von 3.500 US-Dollar ist gefallen, und selbst 4.000 US-Dollar erscheinen nur noch als Zwischenziel.

Die Rallye wird von mehreren Faktoren gleichzeitig getrieben:
  • · massive Käufe durch Noten- und Zentralbanken
  • · Kapitalflucht in sichere Häfen
  • · hohe Nachfrage nach physisch besicherten Gold-ETFs
  • · geopolitische Unsicherheit und Inflationssorgen

Die Aktienkurse vieler Goldproduzenten und Explorer sind in den vergangenen Wochen regelrecht explodiert.

Doch es gibt noch Titel, die Nachholpotenzial besitzen. In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Goldaktien jetzt besonders aussichtsreich sind und warum der Aufwärtstrend noch lange nicht vorbei sein dürfte.

Laden Sie jetzt den Spezialreport kostenlos herunter und profitieren Sie von der historischen Gold-Hausse.

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.